ReachMD Faculty

Public Profile

John Buse, MD, PhD
John Buse, MD, PhD
  • Chief, Division of Endocrinology
  • Director, Diabetes Center
  • NC Translational and Clinical Sciences Institute
  • University of North Carolina School of Medicine
Program NameLast Air DateHosts/Guests
Concentrating on the MOMPOD Trial for Metformin Plus Insulin
  • John Buse, MD, PhD
  • Kim Boggess, MD
Overcoming Obesity: Insights from the SURMOUNT-4 Trial
  • John Buse, MD, PhD
  • Louis J. Aronne, MD, FTOS
Strategies for Addressing Diabetes Stigma and Discrimination05/12/2024
  • John Buse, MD, PhD
  • Mary de Groot, PhD
Challenging the Misconception That T1D Is a Childhood-Onset Disease
  • John Buse, MD, PhD
  • Michael Fang, PhD
Why Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D Patients
  • John Buse, MD, PhD
  • Helen Murphy, PhD
How Overnight Glucose Levels Impact Daily Activities in T1D Patients
  • John Buse, MD, PhD
  • Beth Pyatak, PhD, OTR/L
Decoding Diabetes Diversity: A Study on Heterogeneity and Endotypes in T1D
  • John Buse, MD, PhD
  • Maria Jose Redondo, MD, PhD, MPH
Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts
  • John Buse, MD, PhD
  • Simon Heller, MD
Guiding Principles of Treating Gestational Diabetes03/14/2025
  • John Buse, MD, PhD
  • David Simmons, MD
How Ultra-Processed Foods Increase the Risk of Type 2 Diabetes04/01/2024
  • John Buse, MD, PhD
  • Jean-Philippe Drouin-Chartier, DtP, PhD
Recapping a Narrative Review on the Management of Chronic Kidney Disease in T2D
  • John Buse, MD, PhD
  • David Cherney, MD, PhD
The Impact of RADIANT: A Deep Dive into the Study
  • John Buse, MD, PhD
  • Louis Philipson, MD, PhD
How Diet Can Affect the Gut Microbiome
  • John Buse, MD, PhD
  • Karen D. Corbin, PhD, RD
Key Considerations for CGM Use in Older Adults with T1D03/13/2024
  • John Buse, MD, PhD
  • Anna Kahkoska, MD, PhD
Vitamin D Can Reduce the Risk of T2D in Prediabetic Patients
  • John Buse, MD, PhD
  • Anastassios Pittas, MD, MS
How Hypoglycemia Can Lead to Unsafe Driving Practices in T1D Patients
  • John Buse, MD, PhD
  • Viral Shah, MD
Investigating the Impact of Bempedoic Acid on Cardiovascular Outcomes in Statin-Intolerant Patients
  • John Buse, MD, PhD
  • Steven Nissen, MD
Addressing Gaps to Tackle Obesity in Patients with Type 1 Diabetes02/22/2025
  • John Buse, MD, PhD
  • Elizabeth Selvin, PhD, MPH
Maximizing Weight Loss & Minimizing Side Effects With GLP-1
  • John Buse, MD, PhD
  • Ania Jastreboff, MD, PhD
Closing Gaps in Care for Patients with T2D & CV Disease03/26/2025
  • John Buse, MD, PhD
  • Jennifer B. Green, MD
Adapting Our Exercise Talk: Key Tips on Counseling Patients on Exercise
  • John Buse, MD, PhD
  • Abbie E. Smith-Ryan, PhD, CSCS*D, FNSCA
Key Therapeutic Insights on Semaglutide in Adolescent Obesity
  • John Buse, MD, PhD
  • Silva Arslanian, MD
Explore Impacts Of Glucose-Lowering Medications in Addition to Metformin
  • John Buse, MD, PhD
  • Jennifer B. Green, MD
Key Insights from GRADE: Exploring Data on Glycemia Reduction in T2D07/26/2023
  • John Buse, MD, PhD
  • Deborah Wexler, MD
Insights from Obesity Canada: A Deep Dive into Guideline Updates
  • John Buse, MD, PhD
  • Sue Pedersen, MD, FRCPC
Breaking Down the Bionic Pancreas: A Device for Dosing Decisions for T1D
  • John Buse, MD, PhD
  • Steven Russell, MD, PhD
An Assessment of Automated Insulin Delivery Systems for T1D
  • John Buse, MD, PhD
  • Martin de Bock, PhD FRACP
Getting to Know GRADE: A Comparative Study of T2D Treatment
  • John Buse, MD, PhD
  • Ashok Balasubramanyam, MD
A Look at Comprehensive Telehealth for PPDM
  • John Buse, MD, PhD
  • Matthew Crowley, MD
Exploring Precision Medicine in the Treatment of Diabetes
  • John Buse, MD, PhD
  • Jose C. Florez, MD, PhD
Can Generic Drugs Be Repurposed for COVID-19 Treatment?
  • John Buse, MD, PhD
  • Carolyn Bramante
SNAP, Food Insecurity, & Healthcare Spending: What Do We Need to Know?
  • John Buse, MD, PhD
  • Seth Berkowitz, MD, MPH
A Fight Against Obesity: Evaluating Clinical Data from the SURMOUNT-1 Trial
  • John Buse, MD, PhD
  • Ania Jastreboff, MD, PhD
Exploring AACE Updates on the Management of NAFLD & NASH
  • John Buse, MD, PhD
  • Kenneth Cusi, MD, FACP, FACE
Heart Failure Consensus Report: A Review of ADA Recommendations
  • John Buse, MD, PhD
  • Rodica Pop-Busui, MD, PhD
The IRIS Trial: Reviewing Results & Taking a Look at Pioglitazone10/01/2023
  • John Buse, MD, PhD
  • David Spence, MD
A Review of Emerging Developments & Updated Guidelines on Hyperglycemia Management
  • John Buse, MD, PhD
Investigating Interventions: The Role of Lifestyle Changes in Preventing Diabetes
  • John Buse, MD, PhD
  • Samuel Dagogo-Jack, MD, DSc
Exploring A New Anti-Obesity Treatment
  • John Buse, MD, PhD
  • Domenica M. Rubino, MD
Exploring the Deintensification of Hypoglycemia-Inducing Medications
  • John Buse, MD, PhD
  • Anastasia-Stefania Alexopoulos, MBBS, MHS
Dissecting Clinical Trial Data from the 81st Scientific Sessions03/21/2025
  • John E. Anderson, MD
  • John Buse, MD, PhD
  • Carol Wysham
Debating Diabetic Diets: Considering Keto for Patients with Diabetes
  • John Buse, MD, PhD
Evaluating Early Signs of Diabetes: A Look at Asymptomatic Patients
  • John Buse, MD, PhD
The Diabetic Diet: Key Considerations & Lifestyle Modifications
  • John Buse, MD, PhD
Exploring COVID-19 in Diabetes: A Look at Disease Management & Risk
  • John Buse, MD, PhD
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation03/24/2025
  • John Buse, MD, PhD
  • Anne Louise Peters, MD
When & How to Screen Patients for Diabetes08/01/2021
  • John Buse, MD, PhD
A Wake-Up Call to Diabetes: Spreading Awareness of Its Seriousness07/30/2021
  • John Buse, MD, PhD
Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease03/23/2021
  • John Buse, MD, PhD
  • David Wheeler, MB, CHB, MD, FRCP
Fad Diets & Patients with Type 2 Diabetes05/16/2021
  • John E. Anderson, MD
  • John Buse, MD, PhD
  • Carol Wysham
Dietary Decisions for Patients with Type 2 Diabetes03/23/2021
  • John E. Anderson, MD
  • John Buse, MD, PhD
  • Carol Wysham
Cardio Considerations: Individualized Exercise for Patients with Type 2 Diabetes01/26/2021
  • John E. Anderson, MD
  • John Buse, MD, PhD
  • Carol Wysham
Prescribing Exercise for Patients with Type 2 Diabetes03/23/2021
  • John E. Anderson, MD
  • John Buse, MD, PhD
  • Carol Wysham
Facing Formidable Diabetic Cases with Patient Persistence & Adherence03/23/2021
  • John E. Anderson, MD
  • John Buse, MD, PhD
  • Carol Wysham
Managing Diabetes & COVID-19 in the Wintertime
  • John E. Anderson, MD
  • John Buse, MD, PhD
  • Carol Wysham
Difficulty with Diabetes: Strategies to Overcome Challenging Cases01/21/2021
  • John E. Anderson, MD
  • John Buse, MD, PhD
  • Carol Wysham
Caring for Diabetic Patients During the COVID-19 Pandemic01/25/2021
  • John E. Anderson, MD
  • John Buse, MD, PhD
  • Carol Wysham
New Treatment Algorithm for Type 2 Diabetes12/31/2010
  • John Buse, MD, PhD
  • Steven Edelman, MD
Do Incretins Play An Important Role In the Cardiovascular System?09/11/2009
  • John Buse, MD, PhD
  • Steven Edelman, MD
Special Report: What Went Wrong With ACCORD?07/27/2008
  • John Buse, MD, PhD
  • Matthew J. Sorrentino, MD, FACC, FASH
Diabetes in Children: Refocusing our Practices11/14/2008
  • John Buse, MD, PhD
  • Michael Greenberg, MD
Diabetes: Refocusing our Practices06/15/2008
  • John Buse, MD, PhD
  • Michael Greenberg, MD
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free